Bliss GVS Pharma Ltd.
Snapshot View

76.60 -0.30 ▼-0.4%

12 August 2022, 04:01:00 PM
Volume: 11,393

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.blissgvs.com
Market Cap 795.69 Cr.
Enterprise Value(EV) 722.60 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 1.59 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 48.18 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 80.58 Trailing Twelve Months Ending 2022-06
Price to Book Value 0.95 Calculated using Price: 76.60
Dividend Yield 0.65 Period Ending 2022-03
No. of Shares Subscribed 10.38 Cr. 103,808,172 Shares
FaceValue 1
Company Profile
It is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. The company's most unique product is ‘Today Vaginal Contraceptive', a safe female contraceptive aimed at furthering Planned Parenthood and is also an established method for preventing conception. Bliss also manufactures to US specification vaginal pessaries of Clotrimazole & Povidone Iodine in addition to Anal Suppositories for treatment of piles. The company also manufacture wide range of Pessary Formulations, Suppository Formulations, Calcium Preparation, Protein Powders, Iron Preparation, Antibiotics, Analgesic & Antipyretics, Respiratory, Anti-inflammatory, Dermatological Preparations, Anti-Diarrhoeal products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.39%
1 Week
-2.98%
1 Month
+0.99%
3 Month
+11.09%
6 Month
-17.10%
1 Year
-32.90%
2 Year
-40.64%
5 Year
-52.47%
10 Year
+125.96%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.17 19.74 26.73 25.06 17.34 21.43 13.79 9.64 2.88
Return on Capital Employed (%) 20.56 23.57 32.07 31.06 24.61 26.58 17.02 12.49 6.37
Return on Assets (%) 6.46 9.01 13.04 11.88 9.42 14.35 9.86 7.03 2.12

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 258 287 337 413 487 536 646 736 808 819
Non Curr. Liab. 97 96 68 50 33 13 38 46 45 29
Curr. Liab. 202 308 243 379 437 299 207 231 204 233
Minority Int. 14 10 15 33 66 11 14 15 20 28
Equity & Liab. 571 700 662 874 1,023 860 905 1,027 1,077 1,109
Non Curr. Assets 220 230 245 291 457 170 211 257 312 333
Curr. Assets 349 469 417 583 566 690 693 770 765 776
Misc. Exp. not W/O 2 1 0
Total Assets 571 700 662 874 1,023 860 905 1,027 1,077 1,109

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 345 407 547 798 815 899 689 577 747 768
Other Income 28 20 24 13 27 38 39 22 31 31
Total Income 373 427 571 811 841 936 728 599 779 799
Total Expenditure -273 -304 -391 -596 -618 -741 -566 -471 -629 -645
PBIDT 99 124 180 215 224 195 163 129 150 153
Interest -18 -16 -19 -20 -23 -4 -8 -7 -5 -5
Depreciation -11 -11 -13 -20 -21 -9 -13 -17 -17 -18
Taxation -30 -35 -48 -63 -57 -55 -34 -30 -31 -32
Exceptional Items -34 -13 -74 -74
PAT 41 61 100 113 89 127 95 74 23 24
Minority Interest 0 -1 -18 -31 -30 -3 2 -5 -8 -8
Share Associate
Other Related Items
Consolidated Net Profit 41 60 82 82 59 124 97 68 15 17
Adjusted EPS 4 6 8 8 6 12 9 7 1 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 7 41 38 113 289 18 40 47 64 135
Cash Fr. Inv. -124 -11 -29 -50 -231 50 -74 -48 -47 -93
Cash Fr. Finan. 110 -8 -42 -40 -10 -76 17 -6 -21 -24
Net Change -8 22 -33 23 48 -8 -17 -8 -4 19
Cash & Cash Eqvt 50 50 5 28 47 37 15 15 13 22

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 41.60 41.60 33.31 33.31 33.24 33.19 33.14 33.14 34.51
Public 58.40 58.40 66.69 66.69 66.76 66.81 66.86 66.86 65.49
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.33 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 05 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the extract copies of newspaper advertisement of Unaudited Financial Results of the Company for the quarter ended June 30 2022 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshkati a Regional Daily on August 05 2022.
Wed, 03 Aug 2022
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday August 03 2022
We would like to inform you that Board Meeting of the Company was held today i.e. Wednesday August 03 2022 at the registered office of the Company. In pursuant to Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board has considered and approved the following matter amongst others:1.The Unaudited Standalone and Consolidated Financial Results of the company for the quarter ended June 30 2022. A copy of unaudited financial results along with the Limited Review Report of the Auditors of the Company are enclosed herewith as Annexure - I.
Wed, 27 Jul 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder.

Technical Scans View Details >>

Fri, 12 Aug 2022
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
High Increase 3 Months High Increase 3 Months
High Decrease 1 Year High Decrease 1 Year
Closing Near 50 SMA Closing Near 50 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Divi's Laboratories Ltd. 98,918.90 3,726.20 -5.6%
Cipla Ltd. 82,906.37 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 33.32 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 3.86 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%

FAQ's On Bliss GVS Pharma Ltd.

Can I Buy Bliss GVS Pharma Shares now?

What is the Share Price of Bliss GVS Pharma?

What is the Relative Strength Index (RSI) Value of Bliss GVS Pharma?

What is the Market Capital (MCAP) of Bliss GVS Pharma?

What are the key metrics to analyse Bliss GVS Pharma?

What is the Price Performance of Bliss GVS Pharma?